about
Hip fractures: incidence, risk factors, energy absorption, and preventionHip protectors: recommendations for conducting clinical trials--an international consensus statement (part II)Routine blood tests as predictors of mortality in hip fracture patients.Patient education for alcohol cessation intervention at the time of acute fracture surgery: study protocol for a randomised clinical multi-centre trial on a gold standard programme (Scand-Ankle)Orthogeriatric Service Reduces Mortality in Patients With Hip Fracture.Temporal trends in the use of antithrombotics at admission.Preoperative factors associated with red blood cell transfusion in hip fracture patients.Revision rates for metal-on-metal hip resurfacing and metal-on-metal total hip arthroplasty - a systematic review.Hip fractures in Nordic cities: difference in incidence.Low Levels of Hemoglobin at Admission Are Associated With Increased 30-Day Mortality in Patients With Hip Fracture.Daily number of fractures is associated with road temperature in an urban area.Hyponatremia and hypernatremia are associated with increased 30-day mortality in hip fracture patients.Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice.[Motion sickness]Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in Danish postmenopausal women.Opioid Usage During Admission in Hip Fracture Patients-The Effect of the Continuous Femoral Nerve Block.Leisure-time physical activity levels and changes in relation to risk of hip fracture in men and women.Risk Factors for Post-treatment Complex Regional Pain Syndrome (CRPS): An Analysis of 647 Cases of CRPS from the Danish Patient Compensation Association.Trauma treatment in a role 1 medical facility in Afghanistan.Temporal trends in hip fracture incidence, mortality, and morbidity in Denmark from 1999 to 2012.Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.Late changes in bone mineral density of the proximal tibia following total or partial medial meniscectomy. A randomized study.Association between polymorphisms of apolipoprotein E, bone mineral density of the lower forearm, quantitative ultrasound of the calcaneus and osteoporotic fractures in postmenopausal women with hip or lower forearm fracture.[Schematic hip fracture records and patient documentation. A quality development project]Tobacco smoking and risk of hip fracture in men and womenExcess mortality following hip fracture in patients with diabetes according to age: a nationwide population-based cohort study of 154,047 hip fracture patientsPre-fracture medication use as a predictor of 30-day mortality in hip fracture patients: an analysis of 141,201 patientsProtection against hip fractures by energy absorptionDuodenal output of lactoferrin in normal subjects and correlation to output of amylase, bicarbonate, and total bile acidsDuodenal output and concentration of lactoferrin in chronic pancreatitis: correlation to amylase secretion and duct morphology[Dysbaric osteonecrosis]Heart rate responses to moderate linear body accelerations: clinical implications in aeromedical evacuation[A comparative study of the Lixiscope and conventional X-ray in fracture diagnosis][Retropancreatic abscess. Intermittent lumbar hernia]Changing incidence and residual lifetime risk of common osteoporosis-related fracturesChanges in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A 3-year follow-up of 25 knees[Spigelian hernia caused by fibroma of the uterus]Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patientsDecreased bone density of the distal femur after uncemented knee arthroplasty. A 1-year follow-up of 29 kneesFemoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen
P50
Q28285209-B78B0871-4DDA-4C05-ADEE-F2D9F0252311Q33610045-5990B623-4A23-4289-873E-A50CC867D215Q34124334-AAE0FF7C-20FE-479A-BAA8-728791FD8C86Q35576408-ADB86E25-83AB-4870-A64C-A7274AAE73F2Q36914831-ECA2DA1B-3F54-4B90-8281-9B7435EB37CBQ37139831-CFDB6BA1-763D-4B4B-910E-802E0CEA5046Q38171287-60BE40BE-96DC-40A7-A5BA-3AC630F0321CQ38993491-6251C2CB-93A9-4C22-82A9-93AEEA0DFFEBQ39425292-080E6E10-841D-405B-811B-EB08403F0783Q39463720-4F36D83F-39F5-4D0C-9252-F8644658DCB0Q40190234-E80AC22F-5204-4197-A221-D8F97E7E555EQ40313128-6FCDDB74-100F-4BF0-833A-93EDD72B4F3CQ43745209-F2B7FA79-D677-4DED-8FB5-E33FDACC7DEFQ43907298-1CB92095-240C-4B1D-B605-048C17C9215BQ44136989-A0AFC7F1-3F47-4820-B675-87E98F8E8ED6Q44341365-EF160228-DA0F-491F-9FB3-0652822BAB32Q45157536-2941C986-B7B3-48C1-9DC1-61D68B948D56Q47704426-747275C1-95C8-4551-BB0F-69BD88B66BC4Q48234399-164D966C-C3F4-4D98-B648-B99A2C46C2E1Q49502102-B32ABE37-C53B-48BD-B4CD-27DD55638C76Q51651848-26CF198E-8CBE-4ADB-9182-E779C8D77A87Q53996202-DDD3FF96-BBAD-49C0-AC08-0108FF6D0787Q54758432-34BF1F1C-3C9B-4C76-95C7-732007B5AEECQ61540687-78D1AE29-F19B-4199-BDED-E87BDE6BF1C4Q61875241-63CA9B1D-68F2-45F5-9304-22C029F59C99Q64109156-C59E5712-7839-461B-B011-AB2AB5D73E1AQ64114649-CCEB9463-CE5E-40A4-92EA-001399EDBA59Q68095316-6CBEF866-0541-4D86-9831-0795B9100EEDQ68804485-121FF70C-F435-47F0-B524-C159E4D9DEDEQ68989631-FB1BAF7A-B9E9-4FAD-B885-FC002EE146A6Q69005513-B81D9B88-0BDA-4A04-9C99-73F629A0900DQ69013992-5E34E04C-94EE-4E1A-BE03-A1BA8E9775BCQ69533315-C7EE5C95-9DC0-44AB-8DD7-D0B0AF9CBC11Q70066375-5E4BBF89-4BDC-4D2B-ABB4-4EEBE9C457FCQ70679046-222670EE-4220-4D2E-BB53-92EBC384BFD3Q70879761-30BCC9C0-0495-4D90-9BF8-6F46A9759F38Q70988432-B9C5C037-C821-4784-BB6D-7BF855C965D4Q71447504-D7393607-4FD6-42AC-B468-907E3AD7AD5FQ71500806-D33C6BDB-6A9F-45AD-AB41-45F5146FD1DDQ71697696-3740215D-0F27-4014-838C-80445968CC5A
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Jes Bruun Lauritzen
@en
Lauritzen JB
@ast
Lauritzen JB
@es
Lauritzen JB
@nl
type
label
Jes Bruun Lauritzen
@en
Lauritzen JB
@ast
Lauritzen JB
@es
Lauritzen JB
@nl
altLabel
Lauritzen JB
@en
prefLabel
Jes Bruun Lauritzen
@en
Lauritzen JB
@ast
Lauritzen JB
@es
Lauritzen JB
@nl
P31
P496
0000-0003-4329-2130